Holdings
Silverarc Capital Management, LLC
As of Sep 30, 2026, Silverarc Capital Management, LLC reported 56 positions worth US$705M. Largest: Kodiak Sciences Inc, Celcuity Inc. and Cogent Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kodiak Sciences Inc | 750K | US$71.1M | +204K | Sep 30, 2026 |
| Celcuity Inc. | 803K | US$63.9M | +302K | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 1.57M | US$50.4M | +294K | Sep 30, 2026 |
| Immunome, Inc. | 2.09M | US$45M | +75,706 | Sep 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 3.11M | US$37.1M | +2M | Sep 30, 2026 |
| Sagimet Biosciences Inc. - Series A | 3.75M | US$37M | +818K | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 348K | US$33.2M | +36,856 | Sep 30, 2026 |
| Biogen Inc. | 113K | US$25.5M | +64,689 | Sep 30, 2026 |
| Immunovant, Inc. | 624K | US$21.1M | +4,959 | Sep 30, 2026 |
| Dianthus Therapeutics, Inc. | 237K | US$20.8M | −153K | Sep 30, 2026 |